Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir.

Autor: Moreno A, Quereda C, Montes M, Pérez-Elías MJ, Casado JL, Rodríguez-Sagrado MA, Mateos ML, Dronda F, Bárcena R, Del Campo S, Moreno S
Jazyk: angličtina
Zdroj: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2012 Nov 01; Vol. 61 (3), pp. e47-9.
DOI: 10.1097/QAI.0b013e31826cc275
Databáze: MEDLINE